ELDN   $4.06  5.45% Market Closed After Close 4.18 2.96%

Eledon Pharmaceuticals Inc
Total Cash 83.61M
totalCashPerShare 2.108
EBITDA
Total Debt 655.00K
quickRatio 13.877
currentRatio 14.477
Total Revenue
debtToEquity
Revenue/Share
ROA -0.25799
ROE -2.37387
grossProfits
freeCashflow -20.86M
operatingCashflow -37.90M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 114.93M
forwardPE -4.225
floatShares 35.46M
sharesOutstanding 59.74M
sharesShort 142.85K
sharesShortPriorMonth 83.33K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.32%
Short Ratio help_outline 2.20%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -0.221
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -108.54M
trailingEps 0.45%
forwardEps -1.20%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.31 3Q 2024
institutionsCount 37
lastUpdated Nov. 7, 2024, 4:49 a.m.